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Abstract
The CD4+ T helper (Th) cells have a critical role in organizing the adaptive 
immune response. The emerging cells of the differentiation after the immune 
synapse produce helper T cell subpopulations that activate, suppress, or regulate 
the immune response upon interaction with varying immune cells. There are two 
main Th cell functional categories: the “effector cells” and the “regulatory T cells.” 
Classic T helper lymphocytes can also be distinguished by their lineage according 
to the developmental microenvironment, the expression of cell adhesion-homing 
receptors, the profile of cytokines they are exposed to, and the involved transcrip-
tion factors. Traditionally, the CD4+ and CD8+ phenotypes have been considered 
as helper and cytotoxic/suppressor T lymphocytes, respectively. Currently, the 
distinction is little rigorous. The immune response is exceedingly complex beyond 
the classic Th1 and Th2 effector cells’ involvement, and other populations of 
helper T lymphocytes like the Th17, Tfh, Th22, and Th9 lymphocytes have been 
phenotypically characterized. These lymphocytes also participate in the patho-
genesis of several immune-mediated inflammatory disorders. Here, we revisit and 
discuss the essential aspects of the state of the art regarding phenotypic diversity 
and plasticity of TCD4 cells in the T lymphocyte repertoire frame and their 
potential implication in human inflammatory diseases.
Keywords: CD4+ subsets, inflammation, health, disease, plasticity, diversity,  
CD4+, Th17
1. Introduction
The CD4+ T cells play a key role in triggering various immunological effector 
and regulatory functions, promoting or attenuating inflammation.
Such a diverse repertoire includes the early activation during immune synapses 
in the ganglion, activation of cytotoxic T cells, full activation of macrophages effec-
tor functions, maturation of B cells into plasma cells and memory B cells, antibody 
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production by B cells, immunoglobulin isotype switching, recruitment of PMNs, 
and eosinophil and basophil inflammation [1]. The Th cells promote the amplifica-
tion of inflammatory leukocytes effector activity in a broad spectrum of scenarios 
which under physiological conditions determinate protective and tolerogenic 
immune response. Failure in T effector and/or dysregulated regulatory functions 
could aid immune disorders, including immunodeficiency, autoimmunity, and 
cancer [2–5].
Helper T cells assist in B cells’ differentiation into antibodies-producing plasma 
B cells in a concerted cellular-humoral immune response. This process is triggered 
by specific cytokines and ligand-receptor interactions [6].
The effector T cell phenotype is driven by a specific transcriptional factor, a 
distinctive array of cell surface molecules, and a specific profile of cytokines, which 
along with microenvironmental specific conditions enable T cell subset within an 
arm of the immune system [7].
The Jak/Stat (Janus kinase/signal transducer and activator of transcription) 
pathways [8] and a specific Stat associated with one of the four main transcriptional 
“signature” factors, T-bet (T-box transcription factor), GATA-3, RORγt (retinoic 
acid receptor-related orphan receptor gamma), and Foxp3 (forkhead-box/winged-
helix transcription factor P3), are essential for Th differentiation [9].
Each differentiation pathway requires specific transcription factors: T-bet and 
STAT-4 for Th1 and GATA 3 and STAT 6 for Th2 cells and RORyt for TH17 and 
Foxp3 cells for regulatory T cells (Treg) [10–13].
The T lymphocytes present a remarkable phenotypic, functional, and anatomi-
cal diversity. The T cell lineages are extraordinarily diverse and present a very broad 
functional repertoire (Table 1) bearing innate [14] and adaptive immunogenic 
or tolerogenic immune properties [15, 16]. According to the greater complexity 
and heterogeneity of subsets of T cells, reconsidering the pathogenicity of inflam-
matory diseases beyond the “classical Th1/Th2 paradigm”, Th17 effector cells and 
T-regulatory lymphocytes (Treg) would be appropriate. Relative increases in the 
number of Th9 lymphocytes, follicular helper T cells (Tfh), and Th22 subsets have 
been described, and even NK and NKT cells contribute to the pathogenesis of 
immune-mediated inflammatory diseases [17]. These helper T-cell subtypes trigger 
specific responses upon different tissue environments by expressing a unique set of 
cytokines and chemokine receptors (Figure 1).
The T cells, like the CD1d-restricted natural killer T cells (iNKT) and gamma 
delta T cells, and other “unconventional” T cell subsets with invariant TCRs (T-cell 
receptors) exhibit several characteristics that place them at the border between the 
innate immune system and the adaptive immune system, influencing subsequent 
challenges by the same antigen. Although “unconventional” T cells provide rapidly 
available protection and contribute to the adaptive immune system, they have no 
ordinary helper properties [18].
The natural killer NK (large granular lymphocytes) and NKT (T cells) cells con-
tribute to the pathogenesis of immune-mediated inflammatory diseases (IMIDs). A 
CD4 T cell Th1, Th2, Th3 (iTreg), Th9, Th17, Th22, ThF, nTreg, and Tr1
CD8 T cell Tc1, Tc2, Tc9, and Tc17
Gamma delta T cell Tγδ1 and Tγδ2
Natural killer T cell NKT and NK cells
h, helper; c, cytotoxic; reg, regulatory; n, natural; i, induced
Table 1. 
Representative T cell types.
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large increase in these infiltrating innate immune cells has been observed in IMIDs 
lesions and also in blood as reported for moderate to severe skin psoriasis. In addi-
tion, NKT cells might display different cytokine profiles [19, 20].
Gamma delta T cells express a distinctive surface TCR which, unlike TCRαβ, is 
made up of one γ (gamma) chain and one δ (delta) chain. These cells are abundant 
in the mucosa and do not require antigen processing and major histocompatibility 
complex (MHC) presentation of peptide epitopes [21].
Gamma delta T cells, often tissue-specific, are abundant in the epithelia, orches-
trating immune responses in inflammation, tumor surveillance, infectious disease, 
and autoimmunity.
Gamma delta 1 (Tγδ1) and gamma delta 2 (Tγδ2) cells were defined as a CD3+ cell 
subtype expressing γδ TCR [22]. Phenotypic analysis of gated CD3+ Tγδ1-positive cells 
has revealed that nearly 75% of them are CD4− CD8− (glycoprotein cluster of differentia-
tion). Gamma delta T cells may be regarded as a rapidly available response to pathogens 
triggering the innate and adaptive immune system and a memory phenotype. Besides, 
Figure 1. 
Schematic representation of T lymphocyte differentiation. The T lymphocyte differentiation progresses upon 
the presence of IL12, IFNγ, and other signals provided by the antigen-presenting cells. Each differentiation 
pathway requires specific transcription factors, e.g., T-bet and STAT-4 for Th1 and GATA 3 and STAT 6 for 
Th2 cells, retinoid-related retinoid receptor orphan receptor (ROR t) for TH17, and FOXP3 cells for regulatory 
T cells (Treg). The production of IL12 and IL18 by the immune system cells triggers the early release of IFNγ, 
which influences the natural and adaptive immune response. According to the current differentiation model, 
a new subpopulation known as Th17 or Th IL17, which originates from virgin T helper cells might comprise a 
separate lineage from Th1/Th2. The differentiation of Th17 requires the presence of several factors in humans. 
The IL-23 might be an essential requirement for the development of effector cells. The IL21 might amplify 
the differentiation to Th17. The effector cells may eventually differentiate upon the participation of the aryl 
hydrocarbon receptor AhR, a cytoplasmic receptor that translocates to the nucleus. Although RORγt and AhR 
are highly expressed in the cells, it is unknown whether the AhR is preferentially found in Th17 cells producing 
IL22. The relationship between the Th17 cells producing IL22 and the recently identified Th22 effectors is not 
clear. The Th22 subpopulation typically secretes IL22 and TNFα but not IFNγ, IL4, or IL17. The secretion 
profile includes growth factors and chemokines involved in angiogenesis and fibrosis. TFH, follicular helper  
T lymphocyte; DC, dendritic cell.
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they show potent antigen-presenting properties upon translocation to the ganglion. 
However, the various subsets may also be considered part of the innate immunity where 
a restricted TCR may be used as a pattern recognition receptor, indicating the importance 
of these lymphocytes in immunity and tissue monitoring of pathogens [21].
In particular situations, T CD8 cells can exert helper functions and vice versa, 
regardless of the existing heterogeneity of CD4 and CD8 T cells. Two functionally 
distinctive T lymphocytes subpopulations having effector or regulatory proper-
ties were considered [23]. Currently, the traditional distinction between the CD4 
phenotype as a T helper and the CD8 phenotype as a cytotoxic/suppressor T lym-
phocyte is relative. Both CD4+ lymphocytes with cytotoxic properties and CD8+ 
lymphocytes presenting a secretory profile of cytokines have been identified [24], 
both unable to recognize the antigen in its soluble form.
Like CD4 (+) T cells, under particular conditions, also CD8 (+) T cells express 
different types of interleukins or gain suppressive activity [2]. Certainly, neither 
the heterogeneity of T cells nor the relative cytotoxic capacity of CD8 and CD4 
cells is limited to the mentioned phenotypes. Regarding CD8+ T cells, the prolifera-
tive response prevails over its cytotoxic potential against cells infected by viruses, 
tumors, and allogeneic cells in different situations.
Recent studies have shown differences in the effector function of memory cells 
depending on their localization. While memory cells in the secondary lymphoid 
organs are generally non-cytotoxic, the cells in peripheral tissues show intense 
cytolytic activity. These observations follow the concept developed by Sallusto et al. 
[25], stating that centrally located memory cells expressing CCR7 occupy secondary 
lymphoid organs, whereas effector cells lacking CCR7 remain peripheral.
Figure 2. 
T helper cell plasticity in inflammation. (1) Human Th1 cells originating from virgin CD41 cells in response to 
the coordinated activity of IFN and IL-12 induce stable expression of the transcription factor T-bet. (2) Human 
Th2 cells also originate from naive CD41 cells in response to the combined activity of IL-2 and IL-4, which 
induce stable expression of the GATA3 transcription factor. In the presence of IL-12, T-bet is upregulated in Th2 
cells, which change to produce IFN (Tho). Human Th17 cells originate from a small subset of native CD41 cells 
present in the newborn thymus with receptors IL-23R, IL-1RI, and CCR6 and differentiate into mature Th17 
cells in response to the combined activity of IL-1b and IL-23 in vitro. (3) In the presence of IL-12, the expression 
of T-bet is upregulated in Th17 cells, which change to the production of IFNγ. (4) In the presence of IL-4, 
GATA3 expression is upregulated in Th17/Th1 cells, which progress to nonclassical Th1 cells producing IFNγ.
5Immune-Mediated Inflammation: Human T CD4 Helper Lymphocyte Diversity and Plasticity…
DOI: http://dx.doi.org/10.5772/intechopen.89230
No doubt that the immediate availability of effector memory cells upon infection 
in peripheral tissue is critical to the rapid control of pathogens. Centrally located 
memory cells represent a precursor T population with the ability to acquire effector 
properties after antigen-directed expansion.
Virgin T cells are the most homogeneous subpopulation of T lymphocytes. After 
activation in immunological synapses, lymphocytes differentiate into effector and 
memory cells with a broad phenotypic repertoire. Their properties may obey to 
different maturation programs, localization, and particularities in the antigenic 
presentation. Likewise, CD4 T cells of different lineage show phenotypic plasticity 
[26], eventually shifting into another T cell subset (Figure 2).
2. T-helper cell subtypes 1 and 2
The Th1 and Th2 are the most studied subtypes of helper T cells [27]. They can 
be distinguished by their characteristic cytokine secretion profile, Th1 classically 
producing IFNγ and Th2 producing IL4 and IL5, among other cytokines. Following 
CD4 lymphocyte characterization, different studies have found similitudes for the 
CD8 subpopulations called Tc1 (or type I) and Tc2 (or type II) [28]. At first sight, 
IL12 and IL4 appear critically involved in the differentiation to type I and II cells 
of the CD4 and CD8 subtypes, though the scenario is not that simple. Whereas 
IL21 suppresses type I differentiation and promotes type II differentiation, IL18 
blocks IL4-mediated suppression of type II differentiation and promotes IL12 
receptor expression and type I differentiation. Collectively, different experimental 
outcomes seem to support the existence of factors that stabilize, retard, or reverse 
Th1/Th2 polarization [27]. Likewise, as variations in the secretion profile of 
cytokines do not respond to the prototypical type I and II dichotomy, some authors 
have postulated that Th1/Th2 polarization is artefactual and may not resemble the 
in vivo situation [29].
Recently, transcription factors associated with lymphocyte differentiation like 
T-bet associated with the induction of Th1 differentiation have been characterized 
[30]. Certainly, TCD4 cells lacking T-bet are unable to produce IFNg but release 
large amounts of Th2 cytokines IL4 and IL5. Transcription factor T-bet induces the 
expression of the IL12 receptor and transactivates the IFNg gene. The IL12 derived 
from dendritic cells and macrophages triggers the release of IL12, which induces 
STAT 4 activation in developing Th1 cells by increasing IFNg level and IL18 receptor 
expression [31].
Dendritic cells are also involved in Th2 differentiation. Histamine acting on H1 
and H2 receptors in dendritic cells downregulates IL12 expression and stimulates 
IL10 release, which with the participation of specific transcription factors (GATA-3 
and STAT-6) promotes Th2 differentiation [32].
3. Follicular helper T lymphocyte
Described over a decade ago, T helper lymphocytes with follicle-positive tropism 
(ThF) differ from the classic Th1 and Th2 lymphocytes by expressing an array of 
factors essential to interact with follicular B lymphocytes [33]. The differentia-
tion markers include CXCR5, CD25, CD69, CD95, CD57 (only in humans), OX40 
(CD134), and CD40L (CD154). The homing pattern and functional characteristics 
of ThF have been the subject of intense investigation. The ThF interacts with B 
lymphocytes and modify the type of humoral response inducing long-lived memory 
B cells that release high-affinity antibodies [34].
Cells of the Immune System
6
Curiously, ThF cells dysfunction may induce systemic autoimmunity. The ThF 
cells comprise a TCD4+ subpopulation restricted to the B areas of the lymphatic 
organs, critically involved in the events following the interaction of dendritic cells 
with the virgin T lymphocytes in the secondary lymphatic organ T zone [35]. The 
development of follicular homing capacity by activated T cell helper is the first 
event in the generation of ThF cells. Virgin T cells expressing CD62L and CCR7 
enter the secondary lymphatic organs in the T paracortical lymphoid region, and 
T-lymphocyte activation induces sub-sensitivity to lymphoid chemokines along 
with an increase in follicular chemokines CXCL13 (also known as B cell-attracting 
chemokine BCA-1 or B lymphocyte chemoattractant BLC) [36].
Activated ThF and lymphoblast B lymphocytes express the CXCR5 receptor, which 
confers follicle-positive tropism, and the stroma and dendritic follicular cells express 
the ligand CXCL13. Follicular dendritic cells supply proliferative, antiapoptotic signals, 
and ThF lymphocytes undergo changes increasing antigenic specificity and promote 
the differentiation of lymphoblasts into plasma cells or B lymphocytes with memory. 
The antigen-dependent T-B interaction is critical in triggering the humoral immune 
response [37]. The T-B collaboration is essential to generating short-lived plasma 
cells and inducing the germinal center where they trigger isotype change and somatic 
hypermutation, yielding high-affinity long-lived plasma cells and memory cells [38].
Regarding ThF relationship with Th1, Th2, and Th17 subpopulations, some 
authors mention that ThF cells produce IL4, IFNγ, and IL17, respectively, associated 
with them [39].
4. T helper subtype 9 (Th9) cells
Certain inflammatory conditions give rise to the T helper subtype 9 (Th9) cells 
of unknown functional contribution to the immune response [40, 41]. The in vitro 
development of effector cells specific to constituents of oligodendrocytes (myelin 
oligodendrocyte glycoprotein) Th17, Th1, Th2, and Th9 allowed evaluating the 
encephalitogenic activity in adoptive transfer. All Th1, Th17, and Th9 subpopula-
tions but not Th2 successfully induced experimental allergic encephalitis [23]. The 
Th9 cells might express varied chemokine patterns involved in different immune 
responses. Their effector function balanced by regulatory T cells induces regula-
tory activity restoring homeostasis. This recently described Th9 subset of helper 
lymphocytes may escalate chronic inflammation under certain conditions indepen-
dently from Th1, Th2, Th17, and regulatory T cells [42].
5. T helper subtype 22 cells
Another LT helper subpopulation, the Th22, has been recently identified in epi-
dermic infiltrates in a variety of inflammatory skin disorders, including psoriasis [43]. 
They secrete IL22 and TNFα but not IFNg, IL4, or IL17, and their clones derived from 
psoriatic patients are stable in culture, exhibiting a distinctive transcription profile com-
pared with the already mentioned subpopulations. Secretion profile includes fibroblast 
growth factors and chemokines potentially involved in angiogenesis and fibrosis [44].
6. T helper subtype 17 cells
Differentiation of Th17 cells, like Th1 and Th2 cells, requires the co-participation 
of CD28 and ICOS after the initial stimulus derived from antigenic recognition via 
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the TCR complex (TCR, CD3, ζ chains) for differentiation from virgin CD4+ T cells 
[45]. Ivanov and colleagues suggested that the nuclear receptor ROR gamma T is the 
key transcriptional factor [46] in the differentiation of the Th17 lineage. The Th17 
cells producing IL17 induce inflammatory responses [47].
Differentiation to Th17 requires IL6, TGFβ, and IL23 [48], whereas IL1 and 
TNFα might be involved in Th17 maturation. According to this model, IL27, another 
member of the IL12 family, programs the TCD4+ cells to differentiate to Th1 
inducing the expression of IL12Rβ2. The IL12 is required for the differentiation of 
the programmed cells into Th1 cells producing IFNγ. In turn, IL23, a member of 
the IL12 family [49], triggers the proliferation of Th1 cells from memory cells and 
induces the development of inflammatory Th17 cells [50]. Conversely, IL27 inhibits 
differentiation to Th17 cells by an unknown mechanism suppressing inflammation. 
The relative amount of IL6 and TGFβ in the cellular microenvironment is crucial to 
the severity of inflammation [51].
The proinflammatory cytokine IL-17, originally named IL-17A, has been the 
subject of intense research since its discovery in 1993 [52]. Interest in this cytokine 
increased considerably when its production by a specific subset of CD4 + T cells, the 
so-called Th17 cells [53], was reported. Nevertheless, Th17 lymphocytes can change 
their phenotype to Th1 or Th2 cells depending on the dominant cytokines [2, 54]. 
Figure 2 illustrates how this plasticity can influence arthritis and cardiovascular risk.
Other immune cells subsets can also synthesize and express IL-17, including 
CD8 + T cells (CD8 + IL17 T-cell, or Tc17). Differentiation of CD8 (+) T cells depend 
on the antigen, co-stimulatory molecules, cytokines, and transcription factors 
inducing them to progress to Tc1, Tc2, Tc9, Tc17, or TCD8 [55].
Since Th17 hyperactivation is responsible for the Th17/Treg imbalance in certain 
pathologies, IL-17A might be considered a potential therapeutic target in modulating 
Th1 activity enhancing the regulatory response [56].
7. Regulatory T cells
Following Th3 cell identification and characterization based on their functions 
in the intestinal mucosa, many studies investigated the phenotypic characteristics 
of conventional Treg cells in different tissues and pathological situations. The Th3 
cells (CD4+ TGFβ +) and the Foxp3+ can be induced by oral tolerance, and the TGFβ 
released by iTreg prevents experimental colitis [57]. Though regarded as separate 
lineages, the induced Treg (iTreg) and Th3 cells are substantially superimposed.
Regulatory T cells and maintenance of self-tolerance rely on natural Treg cells, 
typically expressing CD4, CD25, and Foxp3. They develop in the thymus and 
recognize specific autoantigens [58].
The Treg-induced cells (iTreg), another subset of Treg cells, are also gener-
ated in the periphery during an active immune response. In fact, CD4 + CD25− 
cells in the periphery can be converted, in the presence of TGFβ and IL10 into 
CD25 + CD4 + Foxp3 + cells. The iTreg cells induced by IL-10 are called Tr1 cells 
and if induced by TGFβ are called Th3. One subpopulation of nTreg expresses 
activation markers suggesting that it comprises autoreactive Tregs continuously 
activated by tissue autoantigens.
Three suppression mechanisms, not fully elucidated, have been proposed 
to explain the inhibitory actions of Treg cells on activated T cells. These are the 
contact-dependent inhibition between Treg and effector cells, the consumption 
and limitation of growth factors like IL-2, and the inhibition of LT effectors by the 
production of soluble inhibitory cytokines (TGFβ, IL-10, and IL-35) and CTL4 
ligands of the Treg which interacts with the CPA molecules [59].
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Figure 3. 
Modulation of T lymphocyte function by TGFβ factor and its importance in Th1-mediated diseases. TGFb 
released by different types of regulatory cells modulates the inflammatory activity of all effector cells, Th1 cells 
included.
The T-regulatory activity (Treg) is pathologically low in both psoriasis and ath-
erosclerosis [60]. The activity of pathogenic T cells is regulated by Treg cells activity 
via IL-10 and TGFβ [61]. The TGFβ inhibits Th1, and Th2 differentiation favors Th1 
and Th17 hyperactivity [62] in both pathologies [60]. The increase in TGFβ [63] was 
reported inversely correlated with cardiovascular and psoriatic severity.
The critical role of TGFβ and Treg cells was evidenced by the finding that TGFβ-
deficient mice developed multiple inflammatory diseases [64–66].
Both nTreg cells and Tr1-induced cells are able to produce IL10. The relevance of 
IL10 was evidenced by the specific blocking experiments of lymphocyte IL-10 trig-
gering protection against inflammatory processes. The Tr1 cells expressing IL-10 
require the presence of TGFα [67]. Regarding Th2-mediated counterregulation, 
the Th2 produces anti-inflammatory IL-4, IL-5, and IL-13 which decrease Th1 cells 
activity. The proinflammatory, metabolic, and systemic mechanisms that operate 
in the pathogenesis of psoriatic disease may explain the accelerated atherosclerotic 
process in these patients (Figure 3). Serum level of proinflammatory cytokines can 
increase cell-mediated immunity, which upon decreased regulatory Th2 activity 
and Treg level promote endothelial infiltration of inflammatory cells and plaque 
formation [68].
8. Conclusions
The heterogeneity of the T cells in general and TCD4 helper, in particular, may 
reflect divergent pathways in response to epigenetic factors or different stages 
of a unique differentiation pathway. Adhesion molecules, e.g., LFA1 and ICAM, 
CCR and CXCR chemokine receptors, and activation molecules, among others of 
undetermined function, reflect the transition.
The heterogeneity may obey to a programmed developmental process or to 
microenvironmental stimulation. Immunosuppressive or stimulatory signals like 
cytokines seem crucially involved though both may participate. This information is 
expected to shed light on the possible pathogenic role of Th cells in human inflam-
matory diseases beyond the Th1/Th2 paradigm.
The relationships between the classic Th1/ Th2 and the more recently defined 
Th17/iTreg/ Tfh/Th9 cells and effector-regulatory cell interactions need clarifica-
tion regarding their pathogenic role in human inflammatory diseases.
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